Enteral nutrition with homemade formula.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Parents' willingness to cooperate and sign the informed consent form ages 2-18 years hospitalization and Admitted to the PICU stable condition of the person having a NG-Tube above 12 French patients must be able to tolerate Bolus feeding
Exclusion criteria
Exclusion criteria: Liver failure Renal failure Metabolic diseases include glutaric aciduria type 1 and 2, ketoadipic aciduria, isovaleric acidemia, fatty acid oxidation disorder, fructose metabolism disorder, glycogen storage disease, Pku, tyrosinemia, urea cycle disorders, homocystinuria, propionic acidemia, and methylmalonic acidemia Allergy to one of the formula ingredients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tolerance of enteral nutrition (gastric residual volume, diarrhea, constipation, vomiting, abdominal distention). Timepoint: Daily. Method of measurement: Standard 60 cc gavage syringe for aspiration of digestive contents. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: The beginning and end of the intervention. Method of measurement: Weighing with a digital scale with high accuracy.;Subjective Global Nutrition Assessment questionnaire. Timepoint: The beginning and end of the intervention. Method of measurement: Subjective Global Nutrition Assessment questionnaire.;The amount of formula received within 24 hours. Timepoint: Daily. Method of measurement: The amount of the patient received.;Heal to head. Timepoint: The beginning and end of the intervention. Method of measurement: Using a standard meter.;Mid arm circumference. Timepoint: The beginning and end of the intervention. Method of measurement: Using a standard meter.;Number of days in hospital. Timepoint: The end of the intervention. Method of measurement: Number of days of hospitalization.;Complete blood count (CBC). Timepoint: The beginning and end of the intervention. Method of measurement: Using the XN-350 device based on the electrical bioimpedance method In the central laboratory of Akbar Hospital.;Urea. Timepoint: The beginning and end of the intervention. Method of measurement: with BT-3500 device and BIOMED kit based on turbidimetry and colorimetry in the laboratory of Akbar Hospital.;Creatinine. Timepoint: The beginning and end of the intervention. Method of measurement: with BT-3500 device and PARS kit based on turbidimetry and colorimetry in the laboratory of Akbar Hospital.;C – Reative Protein. Timepoint: The beginning and end of the intervention. Method of measurement: Using Ritonbio Analyze Sclave based on the creation of specific antibody against CRP by photometric method in the central laboratory of Akbar Hospital.;Albumin. Timepoint: The beginning and end of the intervention. Method of measurement: with BT-3500 device and PARS kit based on turbidimetry and colorimetry in the laboratory of Akbar Hospital.;Alanine transaminase. Timepoint: The beginning and end of the intervention. Method of measurement: with BT-3500 device and ZIST kit in the | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences